These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


148 related items for PubMed ID: 37626391

  • 1. A cysteine proteinase inhibitor ALLN alleviates bleomycin-induced skin and lung fibrosis.
    Kasamatsu H, Chino T, Hasegawa T, Utsunomiya N, Utsunomiya A, Yamada M, Oyama N, Hasegawa M.
    Arthritis Res Ther; 2023 Aug 25; 25(1):156. PubMed ID: 37626391
    [Abstract] [Full Text] [Related]

  • 2. The compound LG283 inhibits bleomycin-induced skin fibrosis via antagonizing TGF-β signaling.
    Utsunomiya A, Chino T, Kasamatsu H, Hasegawa T, Utsunomiya N, Luong VH, Matsushita T, Sasaki Y, Ogura D, Niwa SI, Oyama N, Hasegawa M.
    Arthritis Res Ther; 2022 Apr 29; 24(1):94. PubMed ID: 35488265
    [Abstract] [Full Text] [Related]

  • 3. Arsenic trioxide inhibits transforming growth factor-β1-induced fibroblast to myofibroblast differentiation in vitro and bleomycin induced lung fibrosis in vivo.
    Luo F, Zhuang Y, Sides MD, Sanchez CG, Shan B, White ES, Lasky JA.
    Respir Res; 2014 Apr 24; 15(1):51. PubMed ID: 24762191
    [Abstract] [Full Text] [Related]

  • 4. Iguratimod inhibits skin fibrosis by regulating TGF-β1/Smad signalling pathway in systemic sclerosis.
    Xie X, Gan H, Tian J, Li F, Chen J, Wang J, Liao J, Li S.
    Eur J Clin Invest; 2022 Aug 24; 52(8):e13791. PubMed ID: 35441708
    [Abstract] [Full Text] [Related]

  • 5. USP7 Promotes TGF-β1 Signaling by De-Ubiquitinating Smad2/Smad3 in Pulmonary Fibrosis.
    Tang F, Gong H, Ke T, Yang W, Yang Y, Liu Z.
    Discov Med; 2024 Aug 24; 36(187):1616-1626. PubMed ID: 39190377
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. 2-Aminoethyl diphenylborinate inhibits bleomycin-induced skin and pulmonary fibrosis via interrupting intracellular Ca2+ regulation.
    Hsu WL, Hsieh YC, Yu HS, Yoshioka T, Wu CY.
    J Dermatol Sci; 2021 Aug 24; 103(2):101-108. PubMed ID: 34315630
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Sulforaphane attenuates pulmonary fibrosis by inhibiting the epithelial-mesenchymal transition.
    Kyung SY, Kim DY, Yoon JY, Son ES, Kim YJ, Park JW, Jeong SH.
    BMC Pharmacol Toxicol; 2018 Apr 02; 19(1):13. PubMed ID: 29609658
    [Abstract] [Full Text] [Related]

  • 12. Crosstalk between the JAK2 and TGF-β1 signaling pathways in scleroderma-related interstitial lung disease targeted by baricitinib.
    Wang D, Wei Y, Xu L, Zhang J.
    Adv Rheumatol; 2023 May 16; 63(1):22. PubMed ID: 37194022
    [Abstract] [Full Text] [Related]

  • 13. Effects of thalidomide on Th17, Treg cells and TGF-β1/Smad3 pathway in a mouse model of systemic sclerosis.
    Lu Y, Zhao C, Lei L, Tao Z, Zheng L, Wen J, Li X.
    Int J Rheum Dis; 2020 Mar 16; 23(3):406-419. PubMed ID: 31840939
    [Abstract] [Full Text] [Related]

  • 14. Biochanin-A ameliorates pulmonary fibrosis by suppressing the TGF-β mediated EMT, myofibroblasts differentiation and collagen deposition in in vitro and in vivo systems.
    Andugulapati SB, Gourishetti K, Tirunavalli SK, Shaikh TB, Sistla R.
    Phytomedicine; 2020 Nov 16; 78():153298. PubMed ID: 32781391
    [Abstract] [Full Text] [Related]

  • 15. Th17 cells and IL-17 promote the skin and lung inflammation and fibrosis process in a bleomycin-induced murine model of systemic sclerosis.
    Lei L, Zhao C, Qin F, He ZY, Wang X, Zhong XN.
    Clin Exp Rheumatol; 2016 Nov 16; 34 Suppl 100(5):14-22. PubMed ID: 26750756
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. COA-Cl prevented TGF-β1-induced CTGF expression by Akt dephosphorylation in normal human dermal fibroblasts, and it attenuated skin fibrosis in mice models of systemic sclerosis.
    Nakai K, Karita S, Igarashi J, Tsukamoto I, Hirano K, Kubota Y.
    J Dermatol Sci; 2019 Apr 16; 94(1):205-212. PubMed ID: 30954335
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Hydrogen inhalation attenuated bleomycin-induced pulmonary fibrosis by inhibiting transforming growth factor-β1 and relevant oxidative stress and epithelial-to-mesenchymal transition.
    Gao L, Jiang D, Geng J, Dong R, Dai H.
    Exp Physiol; 2019 Dec 16; 104(12):1942-1951. PubMed ID: 31535412
    [Abstract] [Full Text] [Related]

  • 20. [Digoxin alleviates pulmonary fibrosis by regulating phosphatidylinositol-3-kinase/Akt signaling through inhibiting the activation of fibroblast: an in vivo and in vitro experiment].
    Jia L, Yang M, Tian X, Zhao P, Mei X, Bai Y.
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2022 Nov 16; 34(11):1161-1166. PubMed ID: 36567559
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.